Access cutting-edge cancer treatment through this clinical trial at a research site in Fairfax. Study-provided care at no cost to qualified participants.
Access cancer specialists in Fairfax at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
This study will evaluate the safety, tolerability, and preliminary efficacy of EIK1004 (IMP1707) in participants with recurrent advanced/metastatic breast cancer, ovarian cancer, metastatic castrate resistant prostate cancer (mCRPC) and pancreatic cancer with deleterious/suspected deleterious mutations of select homologous recombination repair (HRR) genes. Condition or disease Intervention/treatment Phase Advanced Solid Tumors Drug: EIK1004 (IMP1707) Phase 1/Phase 2
Sponsor: Eikon Therapeutics
Check if you qualify for this cancer clinical trial in Fairfax, VA
If you're searching for cancer treatment options in Fairfax, VA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fairfax research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.